AAAAAA

   
Results: 1-9 |
Results: 9
A novel monoclonal antibody specific for the N-terminal end of GAD65
Authors: Hampe, CS Lundgren, P Daniels, TL Hammerle, LP Marcovina, SM Lernmark, A
Citation: Cs. Hampe et al., A novel monoclonal antibody specific for the N-terminal end of GAD65, J NEUROIMM, 113(1), 2001, pp. 63-71
Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding
Authors: Hampe, CS Hammerle, LP Falorni, A Robertson, J Lernmark, A
Citation: Cs. Hampe et al., Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding, FEBS LETTER, 488(3), 2001, pp. 185-189
Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function
Authors: Novak, EJ Ortqvist, E Nord, E Edwall, L Hampe, CS Bekris, L Persson, BE Lernmark, A
Citation: Ej. Novak et al., Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function, DIABET CARE, 23(7), 2000, pp. 1019-1021
Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes
Authors: Hampe, CS Hammerle, LP Bekris, L Ortqvist, E Kockum, I Rolandsson, O Landin-Olsson, M Torn, C Persson, B Lernmark, A
Citation: Cs. Hampe et al., Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes, J CLIN END, 85(12), 2000, pp. 4671-4679
An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases
Authors: Philosof-Oppenheimer, R Hampe, CS Schlessinger, K Fridkin, M Pecht, I
Citation: R. Philosof-oppenheimer et al., An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases, EUR J BIOCH, 267(3), 2000, pp. 703-711
Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations
Authors: Hao, W Davis, C Daniels, T Hampe, CS Lernmark, A
Citation: W. Hao et al., Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations, TRANSFUS M, 9(4), 1999, pp. 307-310
GAD(65) and insulin B chain peptide (9-23) are not primary autoantigens inthe type 1 diabetes syndrome of the BB rat
Authors: Bieg, S Hanlon, C Hampe, CS Benjamin, D Mahoney, CP
Citation: S. Bieg et al., GAD(65) and insulin B chain peptide (9-23) are not primary autoantigens inthe type 1 diabetes syndrome of the BB rat, AUTOIMMUN, 31(1), 1999, pp. 15-24
Species-specific autoantibodies in type 1 diabetes
Authors: Hampe, CS Ortqvist, E Rolandsson, O Landin-Olsson, M Torn, C Agren, A Persson, B Schranz, DB Lernmark, A
Citation: Cs. Hampe et al., Species-specific autoantibodies in type 1 diabetes, J CLIN END, 84(2), 1999, pp. 643-648
Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes
Authors: Hampe, CS Ortqvist, E Persson, B Schranz, DB Lernmark, A
Citation: Cs. Hampe et al., Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes, HORMONE MET, 31(10), 1999, pp. 553-557
Risultati: 1-9 |